210 related articles for article (PubMed ID: 32886325)
1. Human cathelicidin antimicrobial peptide LL-37 promotes lymphangiogenesis in lymphatic endothelial cells through the ERK and Akt signaling pathways.
Yanagisawa T; Ishii M; Takahashi M; Fujishima K; Nishimura M
Mol Biol Rep; 2020 Sep; 47(9):6841-6854. PubMed ID: 32886325
[TBL] [Abstract][Full Text] [Related]
2. Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells.
Coffelt SB; Tomchuck SL; Zwezdaryk KJ; Danka ES; Scandurro AB
Mol Cancer Res; 2009 Jun; 7(6):907-15. PubMed ID: 19491199
[TBL] [Abstract][Full Text] [Related]
3. FPRL1-mediated induction of superoxide in LL-37-stimulated IMR90 human fibroblast.
Iaccio A; Cattaneo F; Mauro M; Ammendola R
Arch Biochem Biophys; 2009 Jan; 481(1):94-100. PubMed ID: 18996352
[TBL] [Abstract][Full Text] [Related]
4. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7.
Nagaoka I; Tamura H; Hirata M
J Immunol; 2006 Mar; 176(5):3044-52. PubMed ID: 16493063
[TBL] [Abstract][Full Text] [Related]
5. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.
De Yang ; Chen Q; Schmidt AP; Anderson GM; Wang JM; Wooters J; Oppenheim JJ; Chertov O
J Exp Med; 2000 Oct; 192(7):1069-74. PubMed ID: 11015447
[TBL] [Abstract][Full Text] [Related]
6. The formyl peptide receptor like-1 and scavenger receptor MARCO are involved in glial cell activation in bacterial meningitis.
Braun BJ; Slowik A; Leib SL; Lucius R; Varoga D; Wruck CJ; Jansen S; Podschun R; Pufe T; Brandenburg LO
J Neuroinflammation; 2011 Feb; 8(1):11. PubMed ID: 21299846
[TBL] [Abstract][Full Text] [Related]
7. LL-37 inhibits serum amyloid A-induced IL-8 production in human neutrophils.
Lee HY; Kim SD; Shim JW; Lee SY; Yun J; Bae YS
Exp Mol Med; 2009 May; 41(5):325-33. PubMed ID: 19307752
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of cyclic phosphatidic acid-induced lymphangiogenic actions in vitro.
Okuyama K; Mizuno K; Nittami K; Sakaue H; Sato T
Microvasc Res; 2022 Jan; 139():104273. PubMed ID: 34699844
[TBL] [Abstract][Full Text] [Related]
9. The human antimicrobial peptide LL-37, but not the mouse ortholog, mCRAMP, can stimulate signaling by poly(I:C) through a FPRL1-dependent pathway.
Singh D; Qi R; Jordan JL; San Mateo L; Kao CC
J Biol Chem; 2013 Mar; 288(12):8258-8268. PubMed ID: 23386607
[TBL] [Abstract][Full Text] [Related]
10. Functional interaction between CTGF and FPRL1 regulates VEGF-A-induced angiogenesis.
Lee MS; Ghim J; Kim SJ; Yun YS; Yoo SA; Suh PG; Kim WU; Ryu SH
Cell Signal; 2015 Jul; 27(7):1439-48. PubMed ID: 25862954
[TBL] [Abstract][Full Text] [Related]
11. Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor.
Girnita A; Zheng H; Grönberg A; Girnita L; Ståhle M
Oncogene; 2012 Jan; 31(3):352-65. PubMed ID: 21685939
[TBL] [Abstract][Full Text] [Related]
12. Piper retrofractum extract and its component piperine promote lymphangiogenesis via an AKT- and ERK-dependent mechanism.
Ishii M; Miyata H; Ikeda N; Tagawa T; Nishimura M
J Food Biochem; 2022 Sep; 46(9):e14233. PubMed ID: 35567300
[TBL] [Abstract][Full Text] [Related]
13. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant.
Kurosaka K; Chen Q; Yarovinsky F; Oppenheim JJ; Yang D
J Immunol; 2005 May; 174(10):6257-65. PubMed ID: 15879124
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia Inhibits Proliferation of Human Dermal Lymphatic Endothelial Cells via Downregulation of Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 Expression.
Xie Q; Shang TY; Feng S; Zhan RC; Liang J; Fan MG; Zhang L; Liu J
Curr Med Sci; 2021 Dec; 41(6):1192-1197. PubMed ID: 34846700
[TBL] [Abstract][Full Text] [Related]
15. LL-37-induced human mast cell activation through G protein-coupled receptor MrgX2.
Yu Y; Zhang Y; Zhang Y; Lai Y; Chen W; Xiao Z; Zhang W; Jin M; Yu B
Int Immunopharmacol; 2017 Aug; 49():6-12. PubMed ID: 28549244
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of Akt and ERK1/2 is required for VEGF-A/VEGFR2-induced proliferation and migration of lymphatic endothelium.
Dellinger MT; Brekken RA
PLoS One; 2011; 6(12):e28947. PubMed ID: 22174934
[TBL] [Abstract][Full Text] [Related]
17. Differential activation of formyl peptide receptor-like 1 by peptide ligands.
Bae YS; Yi HJ; Lee HY; Jo EJ; Kim JI; Lee TG; Ye RD; Kwak JY; Ryu SH
J Immunol; 2003 Dec; 171(12):6807-13. PubMed ID: 14662886
[TBL] [Abstract][Full Text] [Related]
18. Deguelin--an inhibitor to tumor lymphangiogenesis and lymphatic metastasis by downregulation of vascular endothelial cell growth factor-D in lung tumor model.
Hu J; Ye H; Fu A; Chen X; Wang Y; Chen X; Ye X; Xiao W; Duan X; Wei Y; Chen L
Int J Cancer; 2010 Nov; 127(10):2455-66. PubMed ID: 20162567
[TBL] [Abstract][Full Text] [Related]
19. F2L, a peptide derived from heme-binding protein, inhibits LL-37-induced cell proliferation and tube formation in human umbilical vein endothelial cells.
Lee SY; Lee MS; Lee HY; Kim SD; Shim JW; Jo SH; Lee JW; Kim JY; Choi YW; Baek SH; Ryu SH; Bae YS
FEBS Lett; 2008 Jan; 582(2):273-8. PubMed ID: 18083128
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-33 promotes inflammation-induced lymphangiogenesis via ST2/TRAF6-mediated Akt/eNOS/NO signalling pathway.
Han L; Zhang M; Liang X; Jia X; Jia J; Zhao M; Fan Y
Sci Rep; 2017 Sep; 7(1):10602. PubMed ID: 28878285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
